These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32479952)

  • 21. New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries.
    Jain T; Sharma P; Are AC; Vickers SM; Dudeja V
    Front Immunol; 2021; 12():622064. PubMed ID: 33708214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
    Kim J; Lee HK
    Front Immunol; 2021; 12():807648. PubMed ID: 35069592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the microbiome on cancer progression and response to anti-cancer therapies.
    Buchta Rosean C; Feng TY; Azar FN; Rutkowski MR
    Adv Cancer Res; 2019; 143():255-294. PubMed ID: 31202360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the Gut Microbiome to Mitigate Immunotherapy-Induced Colitis in Cancer.
    Chang AE; Golob JL; Schmidt TM; Peltier DC; Lao CD; Tewari M
    Trends Cancer; 2021 Jul; 7(7):583-593. PubMed ID: 33741313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
    Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
    Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapeutic properties of chemotherapy.
    Fournier C; Rivera Vargas T; Martin T; Melis A; Apetoh L
    Curr Opin Pharmacol; 2017 Aug; 35():83-88. PubMed ID: 28551360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in research on the relationship between the gut microbiome and cancer.
    Song P; Wang QB; Liang B; Jiang SJ
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5104-5112. PubMed ID: 34486684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.
    Sevcikova A; Izoldova N; Stevurkova V; Kasperova B; Chovanec M; Ciernikova S; Mego M
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the bacterial microbiome in the treatment of cancer.
    Yu ZK; Xie RL; You R; Liu YP; Chen XY; Chen MY; Huang PY
    BMC Cancer; 2021 Aug; 21(1):934. PubMed ID: 34412621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics.
    Araujo DV; Watson GA; Oliva M; Heirali A; Coburn B; Spreafico A; Siu LL
    Cancer Treat Rev; 2021 Jan; 92():102125. PubMed ID: 33227623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auxiliary antitumor effects of fungal proteins from Hericium erinaceus by target on the gut microbiota.
    Wang D; Zhu X; Tang X; Li H; Yizhen X; Chen D
    J Food Sci; 2020 Jun; 85(6):1872-1890. PubMed ID: 32460371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination.
    Reens AL; Cabral DJ; Liang X; Norton JE; Therien AG; Hazuda DJ; Swaminathan G
    Front Immunol; 2021; 12():643255. PubMed ID: 34054810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer.
    Temraz S; Nassar F; Nasr R; Charafeddine M; Mukherji D; Shamseddine A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of the Fecal Microbiome on Cancer Immunotherapy.
    Osman AEG; Luke JJ
    BioDrugs; 2019 Feb; 33(1):1-7. PubMed ID: 30604388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review.
    Bai J; Behera M; Bruner DW
    Support Care Cancer; 2018 Feb; 26(2):427-439. PubMed ID: 29168036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of modulating the gastrointestinal microbiota in cancer patients.
    Morkūnas E; Skiecevičienė J; Kupčinskas J
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer.
    Wu WK; Ivanova EA; Orekhov AN
    Semin Cancer Biol; 2021 May; 70():85-97. PubMed ID: 32610150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.